Submission of Integrated filing(Financials)for the Quarter and Nine Months ended 31.12.2024 pursuant to SEBI Circular No. SEBI / CFD/CFD-PoD2/CIR/P/2024/185 dated december 31, 2024 read with BSE circular No. 20250102-4 dated 02.01.2025.
Venmax Drugs & Pharmaceuticals Ltd. Press Release Feb 14 2025
Filed with BSE · · 8 pages · English
Release
Venmax Drugs & Pharmaceuticals Ltd. on 6ix
Earlier from Venmax Drugs & Pharmaceuticals
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Feb 10 2025
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Feb 07 2025
- Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Feb 06 2025
Later from Venmax Drugs & Pharmaceuticals
- Board Meeting Outcome for Allotment Of Equity Share Warrants.
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Mar 21 2025
- Closure of Trading Window
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Mar 28 2025
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Follow Venmax Drugs & Pharmaceuticals into a list and get an email when it puts out news.
Follow Venmax Drugs & Pharmaceuticals